OptiMedica Gets $25M
Santa Clara-based OptiMedica, a firm developing medical laser technology for treating retinal disease, has raised $25M as part of a Series D funding round. The funding was disclosed in a regulatory filing. According to the filing, the firm is looking to raised $35M in the funding. Source of the funding was not disclosed. The firm is backed by Kleiner, Perkins, Caufield & Byers and Alloy Venture Partners. OptiMedica's technology was initially developed at Stanford, and is being targeted at treating diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease.
posted on Thursday, August 20, 2009 (Link to more information)
Related companies:
Optimedica
Related stories:
> Optimedica Acquired By Abbott For $400M
silicontap.com Home